Literature DB >> 19393517

Long-term visual outcome of penetrating keratoplasty in infants and children with Peters anomaly.

Lucy L H Yang1, Scott R Lambert, Carolyn Drews-Botsch, R Doyle Stulting.   

Abstract

PURPOSE: To determine the long-term visual outcome of penetrating keratoplasty for Peters anomaly and to identify prognostic factors affecting final vision.
METHODS: The records of children 12 years of age or younger who underwent penetrating keratoplasty for Peters anomaly between January 1, 1971 and December 31, 1992 at Emory University were reviewed. Characteristics of the recipient, eye, donor, and surgical procedure were examined with the use of multivariate analyses.
RESULTS: One hundred forty-four keratoplasties in 72 eyes of 47 children who were followed for a minimum of 3 years from the date of first keratoplasty (median, 11.1 years) were reviewed. Visual acuities ranged from 20/25 to no light perception. Twenty-nine percent of eyes achieved 20/400 or better visual acuities, whereas 38% had light perception or no light perception. Stromal vessels (p < 0.001) and larger donor corneas (p < 0.001) were independent predictors of poor outcome. Postoperative complications included graft failure (n = 44), cataract (n = 15), glaucoma (n = 14), retinal detachment (n = 16), and phthisis (n = 22). More than half of the eyes (n = 18) without graft failure, retinal detachment and/or phthisis saw 20/400 or better.
CONCLUSIONS: Less than one-third of eyes with Peters anomaly undergoing keratoplasty achieved a visual acuity of 20/400 or better. Stromal vessels and large corneal grafts (>or=8 mm) were the only independent predictors of a poor visual outcome.

Entities:  

Mesh:

Year:  2009        PMID: 19393517     DOI: 10.1016/j.jaapos.2008.10.007

Source DB:  PubMed          Journal:  J AAPOS        ISSN: 1091-8531            Impact factor:   1.220


  10 in total

1.  Spontaneous regression of congenital corneal opacity.

Authors:  Sooyeon Choe; Chang Ho Yoon; Mee Kum Kim; Joon Young Hyon; Young Suk Yu; Joo Youn Oh
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2019-11-25       Impact factor: 3.117

2.  Long-term clinical course and visual outcome associated with Peters' anomaly.

Authors:  J W Chang; J H Kim; S-J Kim; Y S Yu
Journal:  Eye (Lond)       Date:  2012-06-29       Impact factor: 3.775

3.  Long-term visual outcomes of penetrating keratoplasty for Peters anomaly.

Authors:  Ji Woong Chang; Mee Kum Kim; Jeong Hun Kim; Seong-Joon Kim; Won Ryang Wee; Young Suk Yu
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2012-10-04       Impact factor: 3.117

4.  [Long-term prognosis of Peters anomaly].

Authors:  S Reichl; D Böhringer; O Richter; W Lagrèze; T Reinhard
Journal:  Ophthalmologe       Date:  2018-04       Impact factor: 1.059

5.  The importance of visual function in the quality of life of children with uveitis.

Authors:  Sheila T Angeles-Han; Kenneth W Griffin; Thomas J A Lehman; John R Rutledge; Stephen Lyman; Joseph T Nguyen; Melanie J Harrison
Journal:  J AAPOS       Date:  2010-03-17       Impact factor: 1.220

6.  Newborn with an absent red reflex.

Authors:  Sanjeev Y Tuli; Beverly P Giordano; Maria Kelly; Donald Fillipps; Sonal S Tuli
Journal:  J Pediatr Health Care       Date:  2011-12-22       Impact factor: 1.812

Review 7.  The challenging management of pediatric corneal transplantation: an overview of surgical and clinical experiences.

Authors:  Antonio Di Zazzo; Stefano Bonini; Salvatore Crugliano; Michele Fortunato
Journal:  Jpn J Ophthalmol       Date:  2017-04-03       Impact factor: 2.447

8.  Type II Peter's anomaly with histopathological proof: a case report.

Authors:  Rui-Qi Chang; Yu Du; Xiang-Jia Zhu; Yi Lu
Journal:  BMC Ophthalmol       Date:  2017-06-29       Impact factor: 2.209

9.  Neonatal corneal ulcer secondary to congenital entropion.

Authors:  Travis K Redd; Robert C Kersten; Davin Ashraf; Lauren Hennein; Gerami D Seitzman
Journal:  Am J Ophthalmol Case Rep       Date:  2022-01-29

10.  Visual Outcomes in Pediatric Patients with Peters Anomaly.

Authors:  Samiksha Fouzdar-Jain; Zena Ibrahim; Jeremy Reitinger; Dingcai Cao; Mehmet C Mocan
Journal:  Clin Ophthalmol       Date:  2021-06-18
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.